ArticleJournal of experimental orthopaedics2025
Long-term outcome of periprosthetic joint infection following unicompartmental knee arthroplasty: A single-centre case series.
Article in Journal of experimental orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Lower re-revision rates after UKA-to-TKA than UKA-to-UKA revision for failed medial unicompartmental knee arthroplasty at mid-term follow-up.Journal of experimental orthopaedics · 2026Article
- Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes.Antibiotics (Basel, Switzerland) · 2025Article
- Long-term outcome of periprosthetic joint infection following unicompartmental knee arthroplasty: A single-centre case series.Journal of experimental orthopaedics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Periprosthetic joint infection (PJI) following unicompartmental knee arthroplasty (UKA) is a rare but serious complication. The data available on this topic are heterogeneous and limited, particularly in regard to long-term survival and patient-reported outcomes (PROs). Therefore, the aim of the present study was to analyse the long-term survival and functional outcome of a case series of PJI following primary UKA at a tertiary referral centre. Methods: Eighteen knees treated for acute or chronic PJI after primary UKA between 2001 and 2020 with a minimum follow-up of 2 years were retrospectively identified and evaluated in the present study. Surgical treatment included debridement, antibiotics and implant retention (DAIR) in 10 patients, and two-stage arthroplasty in 8 patients. Implant survival analysis was conducted using the Kaplan-Meier estimator. Patient-reported outcome measures (PROMs) were used to assess clinical outcomes. Results: Overall implant survival free from any revision at 10 years was 83% (95% confidence interval [CI]: 57%-94%). Three DAIR procedures failed due to persistent infection with partially major complications, resulting in a 10-year revision-free implant survival of 73% (95% CI: 37%-90%). No reoperation was required in the group that underwent staged treatment. There were no long-term revisions due to aseptic loosening or degeneration of other compartments in either group. Both groups demonstrated promising median Oxford Knee Scores, with no significant difference (>0.05) between the DAIR (42, range 11-45) and two-stage exchange arthroplasty (43, range 19-46) groups. Conclusions: Two-stage revision procedure offers excellent long-term survival and high patient satisfaction. The DAIR procedure represents a valid treatment option for acute PJI but carries a certain risk of treatment failure that surgeons should be aware of. Successful treatment of PJI in UKA can provide excellent functional outcomes and long-term survival without an increased risk of low-grade infection and aseptic loosening. Level of Evidence: Level IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.